User menu

Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial.

Bibliographic reference Trappe, Ralf U ; Dierickx, Daan ; Zimmermann, Heiner ; Morschhauser, Franck ; Mollee, Peter ; et. al. Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial.. In: Journal of Clinical Oncology, , p. JCO2016693564 (2016)
Permanent URL http://hdl.handle.net/2078.1/183425